These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25104602)

  • 1. The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment.
    Pedrique B; Strub-Wourgaft N; Some C; Olliaro P; Trouiller P; Ford N; Pécoul B; Bradol JH
    Lancet Glob Health; 2013 Dec; 1(6):e371-9. PubMed ID: 25104602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research and development for neglected diseases: more is still needed, and faster.
    Utzinger J; Keiser J
    Lancet Glob Health; 2013 Dec; 1(6):e317-8. PubMed ID: 25104587
    [No Abstract]   [Full Text] [Related]  

  • 3. Measuring progress in neglected disease drug development.
    Cohen JP; Sturgeon G; Cohen A
    Clin Ther; 2014 Jul; 36(7):1037-42. PubMed ID: 24906971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The United States Food and Drug Administration (FDA) regulatory response to combat neglected tropical diseases (NTDs): A review.
    Mukherjee S
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011010. PubMed ID: 36634043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
    Johnston KL; Ford L; Taylor MJ
    J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global burden of neglected tropical diseases.
    Fenwick A
    Public Health; 2012 Mar; 126(3):233-236. PubMed ID: 22325616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The poverty-related neglected diseases: Why basic research matters.
    Hotez PJ
    PLoS Biol; 2017 Nov; 15(11):e2004186. PubMed ID: 29121043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature.
    Aerts C; Sunyoto T; Tediosi F; Sicuri E
    Health Policy; 2017 Jul; 121(7):745-754. PubMed ID: 28579276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genesis of EDCTP2.
    Zumla A; Makanga M; Nyirenda T; Beattie P; Olesen OF; Breugelmans JG; Aklillu E; Corrah T; Mgone C
    Lancet Infect Dis; 2015 Jan; 15(1):11-3. PubMed ID: 25477021
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.
    Stefanakis R; Robertson AS; Ponder EL; Moree M
    PLoS Negl Trop Dis; 2012; 6(10):e1803. PubMed ID: 23145186
    [No Abstract]   [Full Text] [Related]  

  • 12. New Vaccines for the World's Poorest People.
    Hotez PJ; Bottazzi ME; Strych U
    Annu Rev Med; 2016; 67():405-17. PubMed ID: 26356803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current Trend of Drug Development for Neglected Tropical Diseases (NTDs)].
    Kita K
    Yakugaku Zasshi; 2016; 136(2):205-11. PubMed ID: 26831795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development assistance for neglected tropical diseases: progress since 2009.
    Liese BH; Houghton N; Teplitskaya L
    Int Health; 2014 Sep; 6(3):162-71. PubMed ID: 25096331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
    Yamada H; Hirabayashi F; Brünger C
    Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public-private partnership: from there to here.
    Croft SL
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products.
    Berman J; Radhakrishna T
    Am J Trop Med Hyg; 2017 Jan; 96(1):11-13. PubMed ID: 27573627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Straight talk with...BT Slingsby. Interviewed by Cassandra Willyard.
    Slingsby BT
    Nat Med; 2013 Dec; 19(12):1553. PubMed ID: 24309642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interview with Dr Bernard Pécoul, Executive Director of the Drugs for Neglected Diseases Initiative.
    Pécoul B
    Future Med Chem; 2009 May; 1(2):243-8. PubMed ID: 21425966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
    Ioset JR; Chang S
    Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.